These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34540922)

  • 1. The Utility of Advanced Cardiovascular Imaging in Cancer Patients-When, Why, How, and the Latest Developments.
    Yu C; Pathan F; Tan TC; Negishi K
    Front Cardiovasc Med; 2021; 8():728215. PubMed ID: 34540922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
    Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
    JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.
    Shamai S; Rozenbaum Z; Merimsky O; Derakhshesh M; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Laufer-Perl M
    BMC Cancer; 2020 Jun; 20(1):609. PubMed ID: 32605637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
    Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
    Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.
    Laufer-Perl M; Arnold JH; Mor L; Amrami N; Derakhshesh M; Moshkovits Y; Sadeh B; Arbel Y; Topilsky Y; Rozenbaum Z
    Clin Res Cardiol; 2020 Feb; 109(2):255-262. PubMed ID: 31214777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
    Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy.
    Liu J; Banchs J; Mousavi N; Plana JC; Scherrer-Crosbie M; Thavendiranathan P; Barac A
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1122-1131. PubMed ID: 30092969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization.
    O'Quinn R; Ferrari VA; Daly R; Hundley G; Baldassarre LA; Han Y; Barac A; Arnold A
    JACC CardioOncol; 2021 Jun; 3(2):191-200. PubMed ID: 34396324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk Scores.
    Glen C; Adam S; McDowell K; Waterston A; Tan YY; Petrie MC; Coats CJ; Lang NN
    JACC CardioOncol; 2023 Oct; 5(5):628-637. PubMed ID: 37969652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
    Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
    JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
    Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R
    Intern Med J; 2021 Feb; 51(2):229-234. PubMed ID: 31841257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines.
    Coutinho Cruz M; Moura Branco L; Portugal G; Galrinho A; Timóteo AT; Rio P; Ilhão Moreira R; Mendonça T; Leal A; Gameiro F; Duarte Oliveira S; Luz R; Cruz Ferreira R
    Clin Res Cardiol; 2020 Jun; 109(6):673-684. PubMed ID: 31559482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography and cancer therapeutics-related cardiac dysfunction.
    Tanaka H
    J Med Ultrason (2001); 2019 Jul; 46(3):309-316. PubMed ID: 31030300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients.
    Vallabhaneni S; Zhang KW; Alvarez-Cardona JA; Mitchell JD; Steen H; Woodard PK; Lenihan DJ
    Int J Cardiovasc Imaging; 2021 Oct; 37(10):3003-3017. PubMed ID: 33982196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial.
    Negishi T; Thavendiranathan P; Negishi K; Marwick TH;
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1098-1105. PubMed ID: 29909105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
    Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
    Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac MRI for the evaluation of oncologic cardiotoxicity.
    Löffler AI; Salerno M
    J Nucl Cardiol; 2018 Dec; 25(6):2148-2158. PubMed ID: 29736616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of myocardial strain imaging in surveillance and management of cancer therapeutics-related cardiac dysfunction: A systematic review.
    McGregor PC; Moura FA; Banchs J; Aragam JR
    Echocardiography; 2021 Feb; 38(2):314-328. PubMed ID: 33277729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.